HIGHLIGHTS
- who: Am. J. Trop. Med. and colleagues from the Biology, Swiss Tropical and Public Health Institute, Basel, SwitzerlandBiology, Swiss Tropical and Public Health Institute, Basel, Switzerland have published the research work: Multi-Dose Priming Regimens of PfSPZ Vaccine: Safety and Ef fi cacy against Controlled Human Malaria Infection in Equatoguinean Adults, in the Journal: (JOURNAL) of August/30,/2021
- what: The authors report the results of a randomized, double-blind, NS placebo-controlled clinical trial (EGSPZV3) assessing the safety, immunogenicity, and VE of four different multi-dose priming regimens with or without a delayed booster . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.